A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity

Clinical trial NCT04102189 · COMPLETED

Trial details

NCT number: NCT04102189
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2019-10-07
Primary completion: 2022-03-25
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.